MEDALIST DIVERSIFIED REIT IN (MDRR)

US58403P3038 - REIT

5.77  -0.02 (-0.35%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MDRR. MDRR was compared to 127 industry peers in the Diversified REITs industry. MDRR has a bad profitability rating. Also its financial health evaluation is rather negative. MDRR does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

MDRR had negative earnings in the past year.
MDRR had a positive operating cash flow in the past year.
In the past 5 years MDRR always reported negative net income.
MDRR had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -5.53%, MDRR is doing worse than 94.35% of the companies in the same industry.
MDRR has a Return On Equity of -37.12%. This is amonst the worse of the industry: MDRR underperforms 94.35% of its industry peers.
MDRR has a Return On Invested Capital of 0.74%. This is amonst the worse of the industry: MDRR underperforms 84.68% of its industry peers.
Industry RankSector Rank
ROA -5.53%
ROE -37.12%
ROIC 0.74%
ROA(3y)-5.22%
ROA(5y)-5.92%
ROE(3y)-28.35%
ROE(5y)-35.4%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of MDRR (7.43%) is worse than 85.48% of its industry peers.
MDRR has a better Gross Margin (74.58%) than 69.35% of its industry peers.
In the last couple of years the Gross Margin of MDRR has grown nicely.
Industry RankSector Rank
OM 7.43%
PM (TTM) N/A
GM 74.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.31%
GM growth 5Y10.41%

2

2. Health

2.1 Basic Checks

MDRR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MDRR remains at a similar level compared to 1 year ago.
MDRR has more shares outstanding than it did 5 years ago.
MDRR has a worse debt/assets ratio than last year.

2.2 Solvency

MDRR has an Altman-Z score of -0.34. This is a bad value and indicates that MDRR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.34, MDRR is doing worse than 88.71% of the companies in the same industry.
MDRR has a Debt/Equity ratio of 5.36. This is a high value indicating a heavy dependency on external financing.
MDRR's Debt to Equity ratio of 5.36 is on the low side compared to the rest of the industry. MDRR is outperformed by 87.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF N/A
Altman-Z -0.34
ROIC/WACC0.13
WACC5.87%

2.3 Liquidity

MDRR has a Current Ratio of 1.21. This is a normal value and indicates that MDRR is financially healthy and should not expect problems in meeting its short term obligations.
MDRR has a Current ratio (1.21) which is in line with its industry peers.
A Quick Ratio of 1.21 indicates that MDRR should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.21, MDRR perfoms like the industry average, outperforming 54.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.21

1

3. Growth

3.1 Past

MDRR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.94%.
The Revenue has decreased by -7.33% in the past year.
Measured over the past years, MDRR shows a quite strong growth in Revenue. The Revenue has been growing by 9.29% on average per year.
EPS 1Y (TTM)6.94%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q48.71%
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y3.45%
Revenue growth 5Y9.29%
Revenue growth Q2Q-1.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

MDRR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDRR.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

MDRR has a yearly dividend return of 0.66%, which is pretty low.
Compared to an average industry Dividend Yield of 5.72, MDRR's dividend is way lower than its industry peers. On top of this 92.74% of the companies listed in the same industry pay a better dividend than MDRR!
Compared to an average S&P500 Dividend Yield of 2.34, MDRR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

The dividend of MDRR decreases each year by -57.47%.
MDRR has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-57.47%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MDRR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-8.39%
EPS Next 2YN/A
EPS Next 3YN/A

MEDALIST DIVERSIFIED REIT IN

NASDAQ:MDRR (3/28/2024, 8:23:40 PM)

5.77

-0.02 (-0.35%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap12.92M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.53%
ROE -37.12%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.43%
PM (TTM) N/A
GM 74.58%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 5.36
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.21
Quick Ratio 1.21
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)6.94%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y3.45%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y